CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 38977-39215 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T193","span":{"begin":0,"end":238},"obj":"Sentence"}],"text":"The existence of pathogenic autoantibodies is well established for several peripheral neurological syndromes including myasthenia gravis, Lambert-Eaton syndrome, Guillain-Barré syndrome, and acquired neuromyotonia (Vincent et al., 1999) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T193","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"TextSentencer_T193","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"T10152","span":{"begin":0,"end":238},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The existence of pathogenic autoantibodies is well established for several peripheral neurological syndromes including myasthenia gravis, Lambert-Eaton syndrome, Guillain-Barré syndrome, and acquired neuromyotonia (Vincent et al., 1999) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T145","span":{"begin":119,"end":136},"obj":"Disease"},{"id":"T146","span":{"begin":138,"end":160},"obj":"Disease"},{"id":"T147","span":{"begin":162,"end":185},"obj":"Disease"},{"id":"T148","span":{"begin":191,"end":213},"obj":"Disease"}],"attributes":[{"id":"A145","pred":"mondo_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/MONDO_0009688"},{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0018556"},{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0019399"}],"text":"The existence of pathogenic autoantibodies is well established for several peripheral neurological syndromes including myasthenia gravis, Lambert-Eaton syndrome, Guillain-Barré syndrome, and acquired neuromyotonia (Vincent et al., 1999) ."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T79","span":{"begin":119,"end":129},"obj":"Phenotype"}],"attributes":[{"id":"A79","pred":"hp_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/HP_0003473"}],"text":"The existence of pathogenic autoantibodies is well established for several peripheral neurological syndromes including myasthenia gravis, Lambert-Eaton syndrome, Guillain-Barré syndrome, and acquired neuromyotonia (Vincent et al., 1999) ."}